NEW YORK, April 3, 2015 /PRNewswire/ --

Auspex Pharmaceuticals, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Auspex Pharmaceuticals, Inc. ("ASPX") to Teva Pharmaceutical Industries Ltd. in a cash transaction valued at approximately $3.5 billion or $101.00 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

BioScrip, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of BioScrip, Inc. ("BIOS"). On March 31, 2015, a federal judge denied, in part, a motion to dismiss a complaint alleging that BIOS had made misleading statements pertaining to (i) the distribution of the Novartis Pharmaceutical Corporation's product Exjade® by BIOS' May 2012 divested legacy specialty pharmacy division; and (ii) BIOS' PBM Services segment.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Catamaran Corporation

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Catamaran Corporation ("CTRX") to OptumRx in a transaction valued at $61.50 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Cellular Dynamics International, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Cellular Dynamics International, Inc. ("ICEL") to FUJIFILM Holdings Corporation in a transaction valued at $307 million or $16.50 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

First Security Group, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of First Security Group, Inc. ("FSGI") to Atlantic Capital Bancshares, Inc. in a transaction valued at $160 million or $2.35 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Hyperion Therapeutics, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Hyperion Therapeutics, Inc. to Horizon Pharma plc in a transaction valued at $1.1 billion or $46.00 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Norcraft Companies, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Norcraft Companies, Inc. ("NCFT") to Fortune Brands Home & Security, Inc. in a transaction valued at $600 million or $25.50 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

ATTORNEY ADVERTISING. © 2015 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz & Miller

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: [email protected]

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com

